What is NDC 60687-869?

60687-869 is the product NDC for Digoxin, Digoxin .25 mg/1 tablet, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.

American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Digoxin?

50 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Digoxin NDC 60687-869 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-869Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0869Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-869-01	6068708690160687086901	100 BLISTER PACK in 1 CARTON (60687-869-01) / 1 TABLET in 1 BLISTER PACK (60687-869-11)Marketed from Apr 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Digoxin
Generic name (nonproprietary): digoxin
Active ingredients: Digoxin — .25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: American Health PackagingNDC labeler code 60687
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215307
Marketing start: Apr 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Cardiac Glycosides (Chemical structure)
Identifiers: Product ID 60687-869_31b908f2-f5f7-176f-e063-6294a90a0bf1SPL ID 31b908f2-f5f7-176f-e063-6294a90a0bf1SPL set ID 5500ee2a-077d-486c-b56d-36e0c5e5c31dRxCUI 197604, 197606UNII 73K4184T59
Pharmacologic class: Cardiac Glycoside

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687086901 followed by a unit qualifier and the quantity

Package 60687-0869-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2025.

Indications (excerpt from the label)

Digoxin is a cardiac glycoside indicated for: Treatment of mild to moderate heart failure in adults. (1.1) Increasing myocardial contractility in pediatric patients with heart failure. (1.2) Control of resting ventricular rate in patients with chronic atrial fibrillation in adults. (1.3) 1.1 Heart Failure in Adults Digoxin is indicated for the treatment of mild to moderate heart failure in adults. Digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin should be used in combination wit…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60687-869

What is NDC 60687-869?: 60687-869 is the product NDC for Digoxin, Digoxin .25 mg/1 tablet, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Digoxin.
What is the active ingredient?: Digoxin.
Who is the labeler?: American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Digoxin?: 50 other product NDCs are listed under this name. See all Digoxin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Digoxin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Digoxin	Digoxin .125 mg/1	TabletOral	Coupler LLC	67046-1317	67046-1317-03
Digoxin	Digoxin .125 mg/1	TabletOral	American Health Packaging	60687-858	60687-0858-01
Digoxin	Digoxin .125 mg/1	TabletOral	AvPAK	50268-238	50268-0238-15
Digoxin	Digoxin .125 mg/1	TabletOral	REMEDYREPACK INC.	70518-3859	70518-3859-00
Digoxin	Digoxin .25 mg/1	TabletOral	REMEDYREPACK INC.	70518-3860	70518-3860-00
Digoxin	Digoxin .125 mg/1	TabletOral	Northwind Health Company, LLC	51655-403	51655-0403-52
Digoxin	Digoxin 125 ug/1	TabletOral	Bryant Ranch Prepack	71335-2463	71335-2463-0171335-2463-02
Digoxin	Digoxin 250 ug/1	TabletOral	Bryant Ranch Prepack	71335-2464	71335-2464-0171335-2464-02
Digoxin	Digoxin 250 ug/1	TabletOral	Bryant Ranch Prepack	71335-3156	71335-3156-0171335-3156-0271335-3156-03+1 more
Digoxin	Digoxin 125 ug/1	TabletOral	Bryant Ranch Prepack	72162-2268	72162-2268-0072162-2268-0172162-2268-02+1 more

All 51 Digoxin NDCs

Other NDCs under ANDA 215307

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215307
Product	Strength	Form · route	Labeler	Product NDC
Digoxin	Digoxin .125 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-747
Digoxin	Digoxin .25 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-748
Digoxin	Digoxin .125 mg/1	TabletOral	Northwind Health Company, LLC	51655-403
Digoxin	Digoxin .125 mg/1	TabletOral	American Health Packaging	60687-858
Digoxin	Digoxin .0625 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-200
Digoxin	Digoxin .125 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-201
Digoxin	Digoxin .25 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-202